ArticleDevelopment (Cambridge, England)2026
Spatiotemporal dynamics of ecto-5'-nucleotidase (CD73) in mouse retina under physiological conditions.
Article in Development (Cambridge, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Adenosine is essential for energy metabolism and acts as a neuromodulator in the central nervous system. The retina is a highly energy-demanding neural tissue, and dysregulation of adenosine metabolism contributes to retinal diseases. Although adenosine pathways form extensive compensatory networks, the dynamics of ecto-5'-nucleotidase (CD73), a key enzyme for extracellular adenosine generation, remain elusive. Here, we map its spatiotemporal profile from development to adulthood using two transgenic mouse lines. We found that CD73 became expressed in the rod-photoreceptor lineage by postnatal day (P) 3 and appeared in the inner nuclear layer from P7 onward. Moreover, CD73 was transiently expressed in the astrocyte lineage between embryonic day 16.5 and P3, and the descendants accumulated in the retinal periphery. Functionally, CD73 deletion delayed rod-response recovery and shortened the implicit time in scotopic electroretinography under dim light. These findings suggest that physiological cues such as light and hypoxia may influence CD73 expression and retinal function. Our work lays the groundwork for investigating how genetic and environmental risk factors may alter adenosine metabolism in retinal diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.